Van den Berghe G - Search Results

1

Do we have reliable biochemical markers to predict the outcome of critical illness?

Schetz MR, Van den Berghe G. Schetz MR, et al. Among authors: van den berghe g. Int J Artif Organs. 2005 Dec;28(12):1197-210. doi: 10.1177/039139880502801202. Int J Artif Organs. 2005. PMID: 16404695 Review.

2

Risks of rhG-CSF treatment in drug-induced agranulocytosis.

Demuynck H, Zachée P, Verhoef GE, Schetz M, Van den Berghe G, Lauwers P, Boogaerts MA. Demuynck H, et al. Among authors: van den berghe g. Ann Hematol. 1995 Mar;70(3):143-7. doi: 10.1007/BF01682034. Ann Hematol. 1995. PMID: 7536476

3

Dehydroepiandrosterone sulphate in critical illness: effect of dopamine.

Van den Berghe G, de Zegher F, Wouters P, Schetz M, Verwaest C, Ferdinande P, Lauwers P. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1995 Oct;43(4):457-63. doi: 10.1111/j.1365-2265.1995.tb02618.x. Clin Endocrinol (Oxf). 1995. PMID: 7586621 Clinical Trial.

4

Pharmacokinetics of continuous renal replacement therapy.

Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P. Schetz M, et al. Among authors: van den berghe g. Intensive Care Med. 1995 Jul;21(7):612-20. doi: 10.1007/BF01700172. Intensive Care Med. 1995. PMID: 7593908 Review. No abstract available.

5

Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense?

Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P. Schetz M, et al. Among authors: van den berghe g. Intensive Care Med. 1995 Feb;21(2):169-76. doi: 10.1007/BF01726541. Intensive Care Med. 1995. PMID: 7775699 Review. No abstract available.

6

Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.

Van den Berghe G, de Zegher F, Vlasselaers D, Schetz M, Verwaest C, Ferdinande P, Lauwers P. Van den Berghe G, et al. Crit Care Med. 1996 Apr;24(4):590-5. doi: 10.1097/00003246-199604000-00007. Crit Care Med. 1996. PMID: 8612408 Clinical Trial.

7

Anterior pituitary function during critical illness and dopamine treatment.

Van den Berghe G, de Zegher F. Van den Berghe G, et al. Crit Care Med. 1996 Sep;24(9):1580-90. doi: 10.1097/00003246-199609000-00024. Crit Care Med. 1996. PMID: 8797634 Review.

8

Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.

Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1996 Sep;45(3):341-51. doi: 10.1046/j.1365-2265.1996.00805.x. Clin Endocrinol (Oxf). 1996. PMID: 8949573 Clinical Trial.

9

Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit.

Verwaest C, Verhaegen J, Ferdinande P, Schetz M, Van den Berghe G, Verbist L, Lauwers P. Verwaest C, et al. Among authors: van den berghe g. Crit Care Med. 1997 Jan;25(1):63-71. doi: 10.1097/00003246-199701000-00014. Crit Care Med. 1997. PMID: 8989178 Clinical Trial.

10

The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.

Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY. Van den Berghe G, et al. J Clin Endocrinol Metab. 1997 Feb;82(2):590-9. doi: 10.1210/jcem.82.2.3736. J Clin Endocrinol Metab. 1997. PMID: 9024260 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

624 results

Search Page

Filters